Nonprofit · EIN 52-1524967
HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC
Tax-exempt · BALTIMORE, MD 21205
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $56,806,410 | $63,794,230 | -$6,987,820 | $11,162,925 | $43,121,972 | -$31,959,047 |
| June 30, 2024 | 990 | $49,951,604 | $58,375,748 | -$8,424,144 | $9,968,215 | $33,435,540 | -$23,467,325 |
| June 30, 2023 | 990 | $51,746,241 | $47,896,846 | $3,849,395 | $9,419,338 | $21,003,311 | -$11,583,973 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $50,251,347
- of which government grants
- $28,955,927
- Program service revenue
- $6,555,063
- Investment income
- $0
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $1,399,720
- Other salaries and wages
- $28,056,536
- Salaries, compensation and benefits (total)
- $36,643,211
- Professional fundraising fees
- $0
- Legal fees
- $104,209
- Accounting fees
- $52,470
- Occupancy
- $6,875,903
- Travel
- $447,997
- Program services (functional)
- $57,760,183
- Management and general (functional)
- $6,034,047
Balance sheet and other
- Total assets, start of year
- $9,968,215
- Total assets, end of year
- $11,162,925
- Total liabilities, end of year
- $43,121,972
- Net assets, end of year
- -$31,959,047
- Net assets without donor restrictions
- -$41,212,871
- Net assets with donor restrictions
- $9,253,824
- Gross receipts
- $56,806,410
- Employees
- 463
- Volunteers
- 71
- Year formed
- 1986
- State of legal domicile
- MD
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| BRADLEY L SCHLAGGAR MD PHD | PRESIDENT & CEO Trustee or director, Officer | 5 | $135,608 | $952,706 | $56,146 |
| JAMES M ANDERS JR | COO/ADMINISTRATOR/SECRETARY Officer | 5 | $131,017 | $920,463 | $40,940 |
| SEYED ALI FATEMI MD MBA | CHIEF MEDICAL OFFICER Key employee | 20 | $315,935 | $315,936 | $23,327 |
| MICHAEL F CATALDO PHD | FORMER KEY, PROGRAM DIRECT Former | 0 | $0 | $591,187 | $33,520 |
| MICHAEL J NEUMAN | SVP-FINANCE/TREASURER Officer | 5 | $69,303 | $486,890 | $40,068 |
| AMY BASTIAN PHD PT | CHIEF SCIENCE OFFICER Key employee | 40 | $552,735 | $0 | $34,637 |
| RAYMOND SHORT | SVP - HUMAN RESOURCES Key employee | 5 | $59,155 | $415,593 | $57,946 |
| VALERIE BONHAM | VP - GENERAL COUNSEL (PART YEAR) Key employee | 5 | $62,619 | $439,930 | $21,966 |
| ERIKA AUGUSTINE | ASSOC CHIEF SCIENCE OFFICER Highest-paid employee | 40 | $459,779 | $0 | $57,331 |
| REBECCA LANDA PHD CCC-SLP | FORMER KEY, PROGRAM DIRECTOR Former | 0 | $0 | $414,968 | $38,952 |
| STACY SUSKAUER | VP/PROGRAM DIRECTOR Highest-paid employee | 40 | $397,250 | $0 | $45,346 |
| STEWART MOSTOFSKY MD | PROGRAM DIRECTOR Highest-paid employee | 40 | $363,121 | $0 | $54,998 |
| JOSEPH SCAFIDI | PROGRAM DIRECTOR Highest-paid employee | 40 | $341,632 | $0 | $15,007 |
| ANNE COMI | PROGRAM DIRECTOR Highest-paid employee | 40 | $296,563 | $0 | $16,754 |
| NANCY S GRASMICK ED D | FORMER CHAIRPERSON Former | 0 | $0 | $93,212 | $10,253 |
11 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| RONALD PETERSON | CHAIRPERSON Trustee or director, Officer | 1 | $0 |
| MATTHEW A GOTLIN | VICE CHAIRPERSON Trustee or director, Officer | 1 | $0 |
| MICHAEL J BATZA JR | DIRECTOR Trustee or director | 1 | $0 |
| VAN BROOKS | DIRECTOR Trustee or director | 1 | $0 |
| RICHARD W CASS | DIRECTOR Trustee or director | 1 | $0 |
| STEPHANIE COOPER GREENBERG | DIRECTOR Trustee or director | 1 | $0 |
| DANIEL KOCH | DIRECTOR Trustee or director | 1 | $0 |
| BETH F MCGINN | DIRECTOR Trustee or director | 1 | $0 |
| ANDREW H SEGAL MD | DIRECTOR Trustee or director | 1 | $0 |
| BARBARA SLUSHER PHD MAS | DIRECTOR Trustee or director | 1 | $0 |
| PAUL THESIGER | DIRECTOR Trustee or director | 1 | $0 |
990 for the year ended June 30, 2024: 25 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| BRADLEY L SCHLAGGAR MD PHD | PRESIDENT & CEO Trustee or director, Officer | 5 | $125,701 | $880,418 | $47,955 |
| JAMES M ANDERS JR | COO/ADMINISTRATOR/SECRETARY Officer | 5 | $125,323 | $877,764 | $38,274 |
| SEYED ALI FATEMI MD MBA | CHIEF MEDICAL OFFICER Key employee | 20 | $300,405 | $300,405 | $24,158 |
| MICHAEL F CATALDO PHD | FORMER KEY, PROGRAM DIRECTOR Former | 0 | $0 | $555,225 | $31,737 |
| MICHAEL J NEUMAN | SVP-FINANCE/TREASURER Officer | 5 | $66,774 | $467,687 | $37,575 |
| AMY BASTIAN PHD PT | CHIEF SCIENCE OFFICER Key employee | 40 | $512,855 | $0 | $32,645 |
| RAYMOND SHORT | SVP - HUMAN RESOURCES Key employee | 5 | $57,403 | $402,053 | $53,955 |
| ERIKA AUGUSTINE | ASSOC CHIEF SCIENCE OFFICER Highest-paid employee | 40 | $424,205 | $0 | $53,669 |
| REBECCA LANDA PHD CCC-SLP | FORMER KEY, PROGRAM DIRECTOR Former | 0 | $0 | $396,312 | $26,820 |
| VALERIE BONHAM | VP - GENERAL COUNSEL (PART YEAR) Key employee | 5 | $45,121 | $316,021 | $47,952 |
| STACY SUSKAUER | VP/PROGRAM DIRECTOR Highest-paid employee | 40 | $355,216 | $0 | $38,727 |
| STEWART MOSTOFSKY MD | PROGRAM DIRECTOR Highest-paid employee | 40 | $339,319 | $0 | $50,829 |
| JOSEPH SCAFIDI | PROGRAM DIRECTOR Highest-paid employee | 40 | $319,318 | $0 | $15,684 |
| ANNE COMI | PROGRAM DIRECTOR Highest-paid employee | 40 | $301,267 | $0 | $16,110 |
| NANCY S GRASMICK ED D | CHAIRPERSON Trustee or director, Officer | 1 | $0 | $89,628 | $9,859 |
| RONALD R PETERSON | VICE CHAIRPERSON Trustee or director, Officer | 1 | $0 | $0 | $0 |
| MICHAEL J BATZA JR | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| RICHARD W CASS | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| MATTHEW A GOTLIN | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| DANIEL KOCH | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| BETH F MCGINN | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| GEORGE PETROCHEILOS | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| ANDREW H SEGAL MD | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| BARBARA S SLUSHER PHD MAS | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| ADAM S ZARREN | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
990 for the year ended June 30, 2023: 24 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| BRADLEY L SCHLAGGAR MD PHD | PRESIDENT & CEO Trustee or director, Officer | 5 | $115,267 | $842,593 | $45,924 |
| JAMES M ANDERS JR | SECRETARY Officer | 5 | $114,900 | $839,905 | $36,157 |
| SEYED ALI FATEMI MD MBA | CHIEF MEDICAL OFFICER Key employee | 20 | $284,929 | $284,929 | $19,518 |
| MICHAEL F CATALDO PHD | FORMER KEY, PROGRAM DIRECTOR Former | 0 | $0 | $556,824 | $29,778 |
| MICHAEL J NEUMAN | TREASURER Officer | 5 | $61,827 | $451,952 | $35,532 |
| AMY BASTIAN PHD PT | PROGRAM DIRECTOR/PRINC INV Key employee | 40 | $490,302 | $0 | $30,635 |
| RAYMOND SHORT | SENIOR VP - HUMAN RESOURCE Key employee | 5 | $55,592 | $406,374 | $51,349 |
| ERIKA AUGUSTINE | PROGRAM DIRECTOR Highest-paid employee | 40 | $403,795 | $0 | $48,443 |
| REBECCA LANDA PHD CCC-SLP | FORMER KEY, PROGRAM DIRECTOR Former | 0 | $0 | $374,647 | $35,694 |
| VALERIE BONHAM | VP - GENERAL COUNSEL Key employee | 5 | $42,059 | $307,453 | $43,580 |
| STEWART MOSTOFSKY MD | PROGRAM DIRECTOR/PRINC INV Highest-paid employee | 40 | $327,247 | $0 | $48,179 |
| STACY SUSKAUER | VICE PRESIDENT, ASSOC PROFESSOR Highest-paid employee | 40 | $303,144 | $0 | $34,981 |
| ANNE COMI | PROGRAM DIRECTOR Highest-paid employee | 40 | $289,896 | $0 | $15,491 |
| JOSEPH SCAFIDI | PROGRAM DIRECTOR Highest-paid employee | 40 | $281,231 | $0 | $14,420 |
| NANCY S GRASMICK ED D | CHAIR WOMAN Trustee or director, Officer | 1 | $0 | $86,180 | $9,480 |
| RONALD R PETERSON | VICE CHAIRMAN Trustee or director, Officer | 1 | $0 | $0 | $0 |
| MICHAEL J BATZA JR | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| RICHARD W CASS | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| MATTHEW A GOTLIN | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| BETH F MCGINN | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| GEORGE PETROCHEILOS | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| ANDREW H SEGAL MD | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| BARBARA S SLUSHER PHD MAS | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| ADAM S ZARREN | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 707 N BROADWAY, BALTIMORE, MD 21205-1832
- Principal officer (990 for 2024)
- BRAD L SCHLAGGAR MD PHD, 707 N BROADWAY, BALTIMORE, MD 21205
- Signed the 990
- MICHAEL J NEUMAN, SVP OF FINANCE
- Phone
- (443) 923-9200
- Website
- WWW.KENNEDYKRIEGER.ORG
- Return prepared by
- SC&H GROUP INC
Mission
THE HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC. (THE "RESEARCH INSTITUTE") IS AN INTERNATIONALLY RECOGNIZED RESEARCH FACILITY FINDING ANSWERS TO PROBLEMS AND INJURIES THAT AFFECT A CHILD'S DEVELOPING BRAIN. RESEARCHERS HAVE MADE MEDICAL DISCOVERIES ABOUT THE HUMAN BRAIN AND HAVE INFLUENCED TREATMENT PROGRAMS FOR THOUSANDS OF INDIVIDUALS WITH DISABILITIES. THE MANY STUDIES CURRENTLY BEING CONDUCTED IN AREAS SUCH AS LEARNING DISABILITIES, DOWN SYNDROME, ADRENOLEUKODYSTROPHY, CEREBRAL PALSY AND AUTISM WILL AFFECT AN ENTIRELY NEW GENERATION.
Program accomplishments
- SCIENTISTS AND RESEARCHERS AT THE HUGO W. MOSER RESEARCH INSTITUTE ARE LEADERS IN THE WORLDWIDE EFFORT TO PREVENT AND TREAT DISORDERS OF THE BRAIN, SPINAL CORD, AND MUSCULOSKELETAL SYSTEM. OUR INVESTIGATORS CONTINUE TO BREAK NEW GROUND WITH INNOVATIVE MAGNETIC RESONANCE IMAGING TECHNOLOGY, INVESTIGATE CRITICAL AREAS, SUCH AS THE ROLE OF GENETICS IN DEVELOPMENTAL DISORDERS, AND DEVELOP NEW TREATMENT MODELS AND THERAPIES. KENNEDY KRIEGER IS COMMITTED TO SHARING OUR KNOWLEDGE THAT CAN BE ADAPTED AND USED BY OTHER HEALTHCARE ORGANIZATIONS TO BENEFIT PATIENTS ACROSS THE COUNTRY AND AROUND THE WORLD.AREAS OF RESEARCH ADDRESSED BY THE RESEARCH INSTITUTE INCLUDE THE FOLLOWING:ADVANCED BRAIN IMAGING RESEARCH - THE F.M. KIRBY RESEARCH CENTER FOR FUNCTIONAL BRAIN IMAGING WITHIN THE RESEARCH INSTITUTE IS AN NIH-RECOGNIZED NATIONAL CENTER FOR THE DEVELOPMENT AND APPLICATION OF NEUROIMAGING TECHNOLOGY. RESEARCHERS AT THE KIRBY CENTER USE MRI TECHNOLOGY TO MAP THE ANATOMY, PHYSIOLOGY, BIOCHEMISTRY, CONNECTIVITY AND FUNCTION OF THE BRAIN. INVESTIGATORS AT THE RESEARCH INSTITUTE USE THESE TECHNIQUES TO STUDY AUTISM, ADHD, ADRENOLEUKODYSTROPHY, BRAIN INJURY, CEREBRAL PALSY, LEARNING DISORDERS, RETT'S SYNDROME, AND NUMEROUS OTHER DISORDERS. AUTISM AND NEURO-PSYCHIATRIC DISORDERS RESEARCH - THE PSYCHIATRY DEPARTMENT AND CARD ARE INVOLVED IN RESEARCH PROJECTS WHERE STRIDES TAKEN IN THE UNDERSTANDING OF PSYCHIATRIC DISORDERS AND AUTISM SPECTRUM DISORDERS HAVE IMPROVED THERAPIES FOR THE EMOTIONAL AND BEHAVIORAL DIFFICULTIES OFTEN SEEN IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES.BEHAVIOR AND FEEDING DISORDERS RESEARCH - THE NEUROBEHAVIORAL UNIT HAS A LONG HISTORY OF PRODUCING DATA-BASED RESEARCH IN A NUMBER OF AREAS CRITICAL TO THE DEVELOPMENT AND TREATMENT OF BEHAVIOR DISORDERS. TODAY, THE UNIT SYSTEMATICALLY EXPLORES REFINEMENTS OF THE METHODS OF ASSESSING THE FUNCTIONS OF CHILDREN'S PROBLEM BEHAVIOR.BIOINFORMATICS RESEARCH - BIOINFORMATICS IS THE STUDY OF BIOLOGY USING THE TOOLS OF COMPUTER SCIENCE. BIOINFORMATICS ENABLES THE STUDY OF PROTEINS, GENES, AND GENOMES USING COMPUTER ALGORITHMS AND COMPUTER DATABASES.BRAIN TUMOR RESEARCH - THE RESEARCH INSTITUTE SUPPORTS DIVERSE EFFORTS DEVOTED TO COGNITIVE AND PHYSICAL REHABILITATION OF CHILDREN WITH BRAIN TUMORS, TO UNDERSTANDING HOW TUMORS ALTER FUNCTION OF THE CHILD'S BRAIN AND TO UNDERSTANDING THE CELLULAR AND MOLECULAR PATHWAYS RESPONSIBLE FOR BRAIN TUMOR GROWTH. MORE BASIC RESEARCH USING BRAIN TUMOR ANIMAL MODELS AND CULTURED CELLS TO IDENTIFY NEW MOLECULAR THERAPEUTIC TARGETS AND NOVEL GENES LINKED TO MALIGNANCY IS UNDERTAKEN. NEW THERAPEUTIC APPROACHES ARE BEING DEVELOPED IN COLLABORATIONS WITH BIOTECHNOLOGY COMPANIES.CDC "RISE" (RESEARCH INITIATIVES FOR STUDENT ENHANCEMENT) - RISE IS A CENTER FOR DISEASE CONTROL AND PREVENTION FUNDED RESEARCH EDUCATION PROGRAM FOR GRADUATE AND MEDICAL STUDENTS WHO ARE INTERESTED IN PURSUING RESEARCH EXPERIENCES IN THE FIELD OF PUBLIC HEALTH. STUDENTS WILL HAVE THE OPPORTUNITY TO ENGAGE IN MENTORED RESEARCH EXPERIENCES WITH FACULTY AT KENNEDY KRIEGER INSTITUTE, JHU BLOOMBERG SCHOOL OF PUBLIC HEALTH, AND JOHNS HOPKINS SCHOOL OF MEDICINE FOCUSING ON PUBLIC HEALTH ISSUES RELATED TO CHILDREN. POTENTIAL RESEARCH EXPERIENCES ARE EXPANSIVE AND INCLUDE APPLIED AND LABORATORY STUDIES ENCOMPASSING AREAS SUCH AS ETIOLOGY AND TREATMENT OF MENTAL HEALTH DISORDERS, NEURODEVELOPMENTAL DISORDERS, PHYSICAL AND PSYCHOLOGICAL IMPACT OF URBAN ENVIRONMENTS, AND CHILD MALTREATMENT.CENTER FOR GENETIC DISORDERS OF COGNITION AND BEHAVIOR (THE "GCB CENTER") - THE GCB CENTER FOCUSES ON ADVANCING RESEARCH AND CLINICAL PRACTICE ON GENETIC DISORDERS ASSOCIATED WITH SEVERE COGNITIVE AND BEHAVIORAL IMPAIRMENT, IN ORDER TO IMPROVE THE QUALITY OF LIFE FOR PATIENTS AND THEIR FAMILIES. MAJOR DISORDERS INVESTIGATED BY THE CENTER INCLUDE FRAGILE X SYNDROME, RETT SYNDROME, AND DOWN SYNDROME, ETC.CEREBRAL PALSY AND OTHER MOVEMENT DISORDERS RESEARCH - RESEARCH PROJECTS ARE DESIGNED TO IMPROVE TREATMENT FOR CHILDREN WITH CEREBRAL PALSY, AND ARE FORMULATED ON THE BASIS OF NEEDS OF AFFECTED CHILDREN AND THEIR FAMILIES.GENETIC, METABOLIC, AND DEGENERATIVE BRAIN DISORDERS RESEARCH - MORE THAN A THOUSAND GENETIC DISORDERS THAT LEAD TO ABNORMALITIES OF BRAIN STRUCTURE AND FUNCTION HAVE BEEN IDENTIFIED. THEY INCLUDE A LARGE NUMBER OF NEUROMETABOLIC DISORDERS IN WHICH THE PRECISE BIOCHEMICAL DISTURBANCE HAS BEEN IDENTIFIED. OTHER DISORDERS SUCH AS DOWN SYNDROME, IN WHICH ABNORMALITIES IN THE NUMBER OR STRUCTURE OF CHROMOSOMES OCCURS, HAS ALSO BEEN IDENTIFIED. RECENT IMPROVEMENTS IN TECHNIQUES SUCH AS LIQUID AND HIGH PERFORMANCE CHROMATOGRAPHY, MASS SPECTROMETRY, ENZYMATIC, CYTOGENETICS AND MOLECULAR ANALYSES AND STUDIES IN ANIMAL MODELS OF HUMAN DISEASE STATES HAVE LED TO A BETTER UNDERSTANDING OF HOW THESE DISORDERS DAMAGE THE NERVOUS SYSTEM AND HAVE ALSO LED TO NEW TREATMENTS. THESE TREATMENTS MAY INVOLVE DIET, SPECIAL DIETARY SUPPLEMENTS, PHARMACOLOGICAL AGENTS, AND TRANSPLANTS.LEARNING AND OTHER COGNITIVE DISORDERS RESEARCH - RESEARCHERS AT THE RESEARCH INSTITUTE ARE DEDICATED TO UNDERSTANDING THE MECHANISMS OF LEARNING AND COMMUNICATION DISABILITIES, THEIR PREVENTION, EARLY IDENTIFICATION, AND TREATMENT, WHEN THEY INTERFERE WITH A CHILD'S PROGRESS AT HOME AND IN SCHOOL. THE NEUROLOGIC AND GENETIC BASES FOR SPECIFIC LEARNING DISORDERS, COMMUNICATION DISORDERS AND ATTENTION-DEFICIT DISORDERS ARE BEING INVESTIGATED THROUGH NEUROGENETIC TESTING, NEUROIMAGING AND NEUROPSYCHOLOGICAL EXAMINATION OF NORMAL AND AFFECTED CHILDREN. EARLY IDENTIFICATION EFFORTS INCLUDE NEW TEST DEVELOPMENT AND TRACKING OF HIGH-RISK POPULATIONS. INVESTIGATIONS OF NEW TREATMENT APPROACHES INCLUDE EDUCATIONAL, SOCIAL, LANGUAGE AND PSYCHOLOGICAL INTERVENTIONS, USE OF MEDICATIONS, AND USE OF COMPLEMENTARY THERAPIES IN AFFECTED CHILDREN.MENTAL RETARDATION/ DEVELOPMENTAL DISABILITIES RESEARCH CENTER - THIS CENTER FEATURES INTERDISCIPLINARY COLLABORATION AND A CENTRAL THEME, BRAIN MECHANISMS WHEREBY GENOTYPES RESULT IN A SPECIFIC COGNITIVE AND BEHAVIORAL PHENOTYPES OF MENTAL RETARDATION OR DEVELOPMENTAL DISABILITY.MOLECULAR NEUROSCIENCE RESEARCH - MOLECULAR NEUROSCIENCE STANDS AT THE FRONTIER WHERE RAPID PROGRESS IN MOLECULAR GENETICS CAN BE TRANSLATED INTO THERAPIES FOR NEURODEVELOPMENTAL DISABILITIES FOR WHICH THERE IS CURRENTLY NO TREATMENT. ONE OF THE MOST COMMON CAUSES OF DEVELOPMENTAL BRAIN DISORDERS WORLDWIDE IS DEFICIENCY OF THE HORMONE THYROXINE CAUSED BY A DEFICIENCY OF IODINE. THE RESEARCH INSTITUTE'S PROGRAM IN MOLECULAR NEUROSCIENCE IS MAKING FUNDAMENTAL DISCOVERIES ABOUT HOW THE BRAIN DEVELOPS SO THAT THEY CAN BE TRANSLATED INTO THERAPIES FOR CURRENTLY INCURABLE DISEASES.NEUROBEHAVIORAL RESEARCH UNIT - THE NEUROBEHAVIORAL RESEARCH UNIT (THE "NBRU"), LOCATED WITHIN THE RESEARCH INSTITUTE, IS ONE OF FOUR RESEARCH UNITS OF THE JOHNS HOPKINS UNIVERSITY GENERAL CLINICAL RESEARCH CENTER (THE "GCRC"). THE GCRC PROGRAM WAS ESTABLISHED IN 1960 TO CREATE AND SUSTAIN SPECIALIZED RESOURCES IN WHICH CLINICAL INVESTIGATORS CAN OBSERVE AND STUDY HUMAN PHYSIOLOGY AS WELL AS STUDY AND TREAT DISEASE WITH INNOVATIVE APPROACHES. CENTERS OPERATE AS DISCRETE, MULTI-DEPARTMENTAL, MULTI-CATEGORICAL RESOURCES WHERE SCIENTISTS FROM MANY DEPARTMENTS COMPLEMENT THEIR LABORATORY STUDIES WITH CAREFULLY CONTROLLED CLINICAL INVESTIGATIONS AND ANALYSES. JHU HAS ONE OF THE LARGEST, MOST COMPREHENSIVE GCRCS IN THE UNITED STATES. THE NBRU, UNDER A SUB-CONTRACTUAL AGREEMENT WITH THE GCRC, IS A CLINICAL RESEARCH UNIT DEVOTED TO NEUROBEHAVIOR ANALYSIS WITH A SPECIAL EMPHASIS ON RARE BRAIN DISORDERS.REHABILITATION RESEARCH - THE RESEARCH INSTITUTE'S PROGRAM IN REHABILITATION RESEARCH IS MAKING DISCOVERIES ON BRAIN-BEHAVIOR RELATIONSHIPS; MEASURING, PREDICTING AND IMPROVING OUTCOMES; AND TRANSLATING BASIC SCIENCE TO THE BEDSIDE IN TRIALS AIMED AT IMPROVING THE LIVES OF CHILDREN WITH DISABILITIES.SPINAL CORD INJURY AND PARALYSIS RESEARCH - CLINICAL TRIALS ARE UNDER WAY TO SUPPORT THE VALUE OF ADVANCED RESTORATION THERAPIES IN HELPING INDIVIDUALS WITH SPINAL CORD INJURY RECOVER SENSATION, FUNCTION AND MOBILITY. THE NEXT STEP FOR SPINAL CORD INJURY RESEARCHERS WILL BE EVALUATING THE RESULTS OF CLINICAL TRIALS DESIGNED TO MEASURE THE THERAPIES' EFFICACY. A RETROSPECTIVE TRIAL OF 60 ADULT PATIENTS' RESPONSE TO ADVANCED RESTORATION THERAPIES IS ALREADY UNDERWAY; A NEW COLLABORATION BETWEEN KENNEDY KRIEGER AND PHILADELPHIA'S SHRINER'S HOSPITAL WILL INVOLVE PROSPECTIVE EVALUATION OF THE THERAPY'S IMPACT ON PEDIATRIC SPINAL CORD INJURIES. IN ADDITION TO THE CLINICAL TRIALS, RESEARCHERS ARE EXPLORING NEW WAYS TO PERFORM CELL TRANSPLANTATION.Expenses $57,760,183 · revenue $6,555,063
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 52-1524967
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Hospital or medical research organization
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1987
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Science and technology (U00Z)
- Assets (IRS master file)
- $11,162,925
- Income (IRS master file)
- $56,806,410
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $56,806,410 | $63,794,230 | $11,162,925 | IRS |
| 990 | June 2024 | $49,951,604 | $58,375,748 | $9,968,215 | IRS |
| 990 | June 2023 | $51,746,241 | $47,896,846 | $9,419,338 | XML |
| 990 | June 2022 | $37,126,767 | $41,039,257 | $9,224,078 | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990 | June 2020 | – | – | – | IRS |
| 990 | June 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 52-1524967).
Questions about HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC
- What is the EIN of HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC?
- The employer identification number (EIN) of HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC is 52-1524967.
- Is HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1987.
- Are donations to HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC?
- The 990 for the year ended June 30, 2025 names BRAD L SCHLAGGAR MD PHD.
- Who are the officers and directors of HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC?
- The 990 for the year ended June 30, 2025 lists 26 people; 12 received compensation from the organization, the highest $135,608 (BRADLEY L SCHLAGGAR MD PHD, PRESIDENT & CEO).
- How much revenue does HUGO W MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER INC have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $56,806,410, expenses of $63,794,230 and total assets of $11,162,925 at year end.
Other nonprofits in BALTIMORE
- NATIONAL INFORMATION STANDARDS ORGANIZATION Z39 EIN 52-1394717 · last filed 990 for 2023
- CSRM FOUNDATION INC EIN 30-0690654 · last filed 990 for 2025
- ABET FOUNDATION INC EIN 26-3542581 · last filed 990-EZ for 2024
- INTERNATIONAL SOCIETY FOR NUCLEOTIDES & NUCLEIC ACIDS EIN 63-1284546 · last filed 990 for 2025
- WEARABLE TECH VENTURES INC EIN 83-4427792 · last filed 990-EZ for 2025
- MARYLAND SCIENCE OLYMPIAD INC EIN 74-3234318 · last filed 990-N for 2025
- GENOMIC STANDARDS CONSORTIUM EIN 88-4128548 · last filed 990-N for 2025
- JUXTOPIA GROUP INC EIN 52-2258677 · last filed 990-N for 2024
All nonprofits in BALTIMORE · Maryland · Science and technology